Scarica l'app Stockscreener
37.79
0.21%
-0.08
Dopo l'orario di chiusura:
37.00
-0.79
-2.09%
Precedente Chiudi:
$37.87
Aprire:
$37.85
Volume 24 ore:
272.79K
Relative Volume:
0.32
Capitalizzazione di mercato:
$1.74B
Reddito:
-
Utile/perdita netta:
$-146.66M
Rapporto P/E:
-13.72
EPS:
-2.7541
Flusso di cassa netto:
$-133.21M
1 W Prestazione:
+4.91%
1M Prestazione:
-7.42%
6M Prestazione:
+23.78%
1 anno Prestazione:
-20.49%
Intervallo 1D:
$37.47
$38.46
Intervallo di 1 settimana:
$35.57
$38.88
Portata 52W:
$26.20
$63.50
Apogee Therapeutics Inc Stock (APGE) Company Profile
Nome
Apogee Therapeutics Inc
Settore
Industria
Telefono
650-394-5230
Indirizzo
221 CRESCENT ST., WALTHAM
Confronta APGE con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
APGE
Apogee Therapeutics Inc
|
37.79 | 2.26B | 0 | -146.66M | -133.21M | -2.7541 |
|
VRTX
Vertex Pharmaceuticals Inc
|
389.08 | 99.27B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
586.96 | 62.28B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.18 | 59.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
707.96 | 43.34B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
300.14 | 36.72B | 3.81B | -644.79M | -669.77M | -6.24 |
Apogee Therapeutics Inc Stock (APGE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-07 | Reiterato | BTIG Research | Buy |
| 2025-03-13 | Iniziato | Citigroup | Buy |
| 2024-11-25 | Iniziato | Canaccord Genuity | Buy |
| 2024-05-10 | Iniziato | BofA Securities | Buy |
| 2023-12-20 | Iniziato | BTIG Research | Buy |
| 2023-08-08 | Iniziato | Guggenheim | Buy |
| 2023-08-08 | Iniziato | Jefferies | Buy |
| 2023-08-08 | Iniziato | Stifel | Buy |
| 2023-08-08 | Iniziato | TD Cowen | Outperform |
| 2023-08-08 | Iniziato | Wedbush | Outperform |
Mostra tutto
Apogee Therapeutics Inc Borsa (APGE) Ultime notizie
Apogee Therapeutics Inc. stock daily chart insightsTrade Volume Summary & Real-Time Buy Zone Alerts - Newser
Volume spikes in Apogee Therapeutics Inc. stock – what they meanProduct Launch & Free Community Supported Trade Ideas - Newser
Why Apogee Therapeutics Inc. is moving todayJuly 2025 Trade Ideas & AI Based Buy and Sell Signals - Newser
Can Apogee Therapeutics Inc. hit a new high this monthFed Meeting & Daily Risk Controlled Trade Plans - Newser
Smart tools for monitoring Apogee Therapeutics Inc.’s price actionMarket Risk Analysis & Pattern Based Trade Signal System - Newser
Historical volatility pattern of Apogee Therapeutics Inc. visualized2025 Top Decliners & Verified Swing Trading Watchlist - Newser
Exit strategy if you’re trapped in Apogee Therapeutics Inc.July 2025 Movers & Real-Time Volume Analysis Alerts - Newser
Apogee Therapeutics Inc. stock momentum explainedEarnings Overview Summary & Real-Time Chart Pattern Alerts - Newser
Apogee Therapeutics Inc. stock trend forecastDay Trade & AI Powered Market Trend Analysis - Newser
What the charts say about Apogee Therapeutics Inc. todayMarket Growth Report & Technical Analysis for Trade Confirmation - Newser
Understanding Apogee Therapeutics Inc.’s price movementJuly 2025 EndofMonth & Safe Entry Trade Reports - Newser
Analyzing recovery setups for Apogee Therapeutics Inc. investorsWeekly Profit Analysis & AI Forecasted Stock Moves - Newser
Will a bounce in Apogee Therapeutics Inc. offer an exitJuly 2025 Snapshot & Entry and Exit Point Strategies - Newser
Earnings visualization tools for Apogee Therapeutics Inc.Weekly Trade Recap & Weekly Hot Stock Watchlists - Newser
Price Channel Expanding on Apogee Therapeutics Inc.’s ChartJuly 2025 Setups & AI Based Trade Execution Alerts - newsyoung.net
Is Apogee Therapeutics Inc. meeting your algorithmic filter criteria2025 AllTime Highs & Weekly Top Gainers Trade List - Newser
Detecting price anomalies in Apogee Therapeutics Inc. with AIWeekly Earnings Recap & Low Volatility Stock Suggestions - Newser
When is the best time to exit Apogee Therapeutics Inc.July 2025 Outlook & Short-Term High Return Strategies - Newser
Key resistance and support levels for Apogee Therapeutics Inc.July 2025 Final Week & High Yield Stock Recommendations - Newser
Is Apogee Therapeutics Inc. a top pick in the sectorExit Point & Daily Oversold Bounce Ideas - theviewers.co.kr
Custom watchlist performance reports with Apogee Therapeutics Inc.Trend Reversal & Fast Exit/Entry Strategy Plans - Newser
Comparing Apogee Therapeutics Inc. in custom built stock radars2025 Key Highlights & AI Enhanced Trading Signals - Newser
Is this a good reentry point in Apogee Therapeutics Inc.Earnings Risk Report & Weekly Top Stock Performers List - Newser
What makes Apogee Therapeutics Inc. stock price move sharply2025 Trade Ideas & Fast Entry Momentum Trade Alerts - Newser
Relative strength of Apogee Therapeutics Inc. in sector analysisQuarterly Trade Summary & Weekly Sector Rotation Insights - Newser
BTIG Raises PT on Apogee Therapeutics (APGE) to $115 From $100, Keeps a Buy Rating - MSN
Best data tools to analyze Apogee Therapeutics Inc. stock2025 Winners & Losers & High Win Rate Trade Tips - Newser
What’s next for Apogee Therapeutics Inc. stock price2025 Dividend Review & Breakout Confirmation Trade Signals - Newser
Apogee Therapeutics Inc. Company Revenue and Profit Trends: A Deep Dive2025 Price Action Summary & Reliable Entry Point Trade Alerts - Newser
Apogee Therapeutics (NASDAQ:APGE) Given "Outperform" Rating at Wedbush - MarketBeat
Apogee Therapeutics Faces Supply Chain Risks Amid Geopolitical Tensions and Regulatory Challenges - MSN
Apogee Therapeutics (APGE) Falls 17%, Positive Trial Results Fail to Impress Investors - MSN
Apogee Therapeutics (APGE) Is Up 5.9% After Strong APG777 Phase 2 Data and Accelerated Plans - uk.finance.yahoo.com
Apogee Therapeutics Reports Promising Trial Results and Strong Cash Position - TipRanks
Intrinsic Value of Apogee Therapeutics Inc. Stock: Is It Undervalued or OvervaluedJuly 2025 Snapshot & Fast Moving Market Watchlists - Newser
Apogee Therapeutics Inc Azioni (APGE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apogee Therapeutics Inc Azioni (APGE) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Dambkowski Carl | Chief Medical Officer |
Jul 02 '25 |
Option Exercise |
22.86 |
7,365 |
168,364 |
249,088 |
| Dambkowski Carl | Chief Medical Officer |
Jul 02 '25 |
Sale |
45.09 |
10,090 |
454,954 |
238,998 |
0.98%
8.06%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):